LeadIQ logo
Learn more at LeadIQ.com

Insights

Loading spinner
Gathering insights about Emendo Biotherapeutics

Similar companies to Emendo Biotherapeutics

Emendo Biotherapeutics Tech Stack

Emendo Biotherapeutics uses 8 technology products and services including Cloudflare, Google Cloud, HTTP/3, and more. Explore Emendo Biotherapeutics's tech stack below.

  • Cloudflare
    Content Management System
  • Google Cloud
    Infrastructure As A Service
  • HTTP/3
    Miscellaneous
  • PHP
    Programming Languages
  • Python
    Programming Languages
  • Google Tag Manager
    Tag Management
  • Plyr
    Video Players
  • Nginx
    Web Servers

Emendo Biotherapeutics's Email Address Formats

Emendo Biotherapeutics uses at least 1 format(s):
Emendo Biotherapeutics Email FormatsExamplePercentage
First@emendobio.comJohn@emendobio.com
67%
FirstL@emendobio.comJohnD@emendobio.com
29%
Last@emendobio.comDoe@emendobio.com
2%
First.Last@emendobio.comJohn.Doe@emendobio.com
2%

Frequently Asked Questions

Where is Emendo Biotherapeutics's headquarters located?

Minus sign iconPlus sign icon
Emendo Biotherapeutics's main headquarters is located at 400w E 61st St New York, New York 10065 US. The company has employees across 5 continents, including AsiaNorth AmericaAfrica.

What is Emendo Biotherapeutics's official website and social media links?

Minus sign iconPlus sign icon
Emendo Biotherapeutics's official website is emendobio.com and has social profiles on LinkedIn.

How much revenue does Emendo Biotherapeutics generate?

Minus sign iconPlus sign icon
As of October 2024, Emendo Biotherapeutics's annual revenue reached $15M.

What is Emendo Biotherapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
Emendo Biotherapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Emendo Biotherapeutics have currently?

Minus sign iconPlus sign icon
As of October 2024, Emendo Biotherapeutics has approximately 57 employees across 5 continents, including AsiaNorth AmericaAfrica. Key team members include Chief Financial Officer: R. A.Vice President Of Business Development | Cutting Edge Novel Nuclease Gene Editing Platform: P. K.Head Of Scientific Projects, Computational Biology Department: N. M.. Explore Emendo Biotherapeutics's employee directory with LeadIQ.

What industry does Emendo Biotherapeutics belong to?

Minus sign iconPlus sign icon
Emendo Biotherapeutics operates in the Biotechnology Research industry.

What technology does Emendo Biotherapeutics use?

Minus sign iconPlus sign icon
Emendo Biotherapeutics's tech stack includes CloudflareGoogle CloudHTTP/3PHPPythonGoogle Tag ManagerPlyrNginx.

What is Emendo Biotherapeutics's email format?

Minus sign iconPlus sign icon
Emendo Biotherapeutics's email format typically follows the pattern of . Find more Emendo Biotherapeutics email formats with LeadIQ.

How much funding has Emendo Biotherapeutics raised to date?

Minus sign iconPlus sign icon
As of October 2024, Emendo Biotherapeutics has raised $250M in funding. The last funding round occurred on Dec 15, 2020 for $250M.

When was Emendo Biotherapeutics founded?

Minus sign iconPlus sign icon
Emendo Biotherapeutics was founded in 2015.
Emendo Biotherapeutics

Emendo Biotherapeutics

Biotechnology ResearchNew York, United States51-200 Employees

Emendo Biotherapeutics develops next generation gene editing tools for genetic disorders, addressing the current technological gaps for realizing the promise of gene therapy.  

We leverage our expertise in protein engineering to bring innovative and disruptive protein tools to resolve the bottleneck of the field.

Section iconCompany Overview

Headquarters
400w E 61st St New York, New York 10065 US
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2015
Employees
51-200

Section iconFunding & Financials

  • $250M

    Emendo Biotherapeutics has raised a total of $250M of funding over 3 rounds. Their latest funding round was raised on Dec 15, 2020 in the amount of $250M.

  • $10M$50M

    Emendo Biotherapeutics's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $250M

    Emendo Biotherapeutics has raised a total of $250M of funding over 3 rounds. Their latest funding round was raised on Dec 15, 2020 in the amount of $250M.

  • $10M$50M

    Emendo Biotherapeutics's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.